Interstitial pneumonitis associated with pegylated interferon α-2b therapy for chronic hepatitis C: Case report

Interstitial pneumonitis associated with pegylated interferon α-2b therapy for chronic hepatitis C: Case report

Since 2004, pegylated interferon (P-IFN) in combination with ribavirin has become the optimal choice of therapy for chronic hepatitis C virus (HCV) infection. IFN α-2b suppresses HCV replication and restores elevated serum aminotransferase levels, leading to improvements in the histological changes...

Full description

Bibliographic Details
Main Authors: Raúl Carrillo-Esper, Daniela González-Avila, Marittza Uribe-Ríos, Nahum Méndez-Sánchez, MD, PhD.
Format: Article
Language:English
Published: Elsevier 2008-01-01
Series:Annals of Hepatology
Subjects:
Chronic hepatitis C
liver cirrhosis
pegylated interferon
interstitial pneumonitis
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119318952

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119318952

Similar Items